Pyrrolidine dithiocarbamate attenuate shock wave induced MDCK cells injury via inhibiting nuclear factor-kappa B

Xiang Li1, Dalin He, Linlin Zhang

  • 1Department of Urology, No. 1 Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi Province 710061, China.

Urological Research
|June 15, 2007
PubMed

Insights

Shock wave lithotripsy (SWL) causes kidney damage through Nuclear factor-kappa B (NFkappaB) activation, leading to harmful enzyme production. Inhibiting this pathway with pyrrolidine dithiocarbamate (PDTC) protects kidney cells from SWL-induced injury.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cellular Biology

Background:

  • Shock wave lithotripsy (SWL) can cause kidney damage, potentially through mechanisms similar to ischemia reperfusion injury.
  • Nuclear factor-kappa B (NFkappaB) and its downstream targets, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), are implicated in cellular injury.

Purpose of the Study:

  • To investigate the role of NFkappaB and its target enzymes in SWL-induced renal cellular damage using an in vitro model.
  • To evaluate the protective effect of pyrrolidine dithiocarbamate (PDTC) in inhibiting this pathway and mitigating SWL-induced cell damage.

Main Methods:

  • MDCK cells were exposed to SWL with or without PDTC treatment.
  • Cell damage markers (MDA, LDH) and NFkappaB pathway activation (NFkappaBp65 translocation, IkappaB-a degradation, iNOS, COX-2 expression) were assessed at various time points post-SWL.

Main Results:

  • SWL induced NFkappaB activation, increasing iNOS and COX-2 expression.
  • PDTC treatment reduced iNOS expression, MDA levels, and LDH release.
  • PDTC did not significantly alter COX-2 expression levels compared to SWL alone.

Conclusions:

  • NFkappaB activation and subsequent cytotoxic enzyme expression are key mechanisms in SWL-induced renal cell damage.
  • Inhibiting the NFkappaB pathway with PDTC offers protection against SWL-induced cellular damage, particularly by reducing iNOS levels.